Events & Training

European Artificial Intelligence Summit

05 March 2018 - 06 March 2018

The implementation, data privacy, and operational challenges facing life science and healthcare professionals dedicated to integrating AI into their organization vastly differ by therapeutic area and patient population, size of the organization, and the number of resources available to them. Cookie-cutter solutions cannot address the unique challenges faced by a company. It is critical that the education available to these professionals meets the varying needs of the industry. As such, ExL Events has expanded its Artificial Intelligence conference series to now introduce the European Artificial Intelligence Innovation Summit. Through keynotes, panel discussions, and case studies, the executive speaking faculty provides key insights into the ethical standards of AI; explores the realistic steps to achieve successful AI execution; defines the regulatory boundaries and limitations; reviews the necessary metrics to measure the success and efficacy of the AI system; and examines case studies on industry vertical use.

Hilton London Kensington, London, UK

12th Annual Paediatric Clinical Trials

19 March 2018 - 20 March 2018

Clinical trials in paediatric populations still pose several challenges and often many studies remain un- published*. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno- oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines. Join us as we discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. leading industry experts will be looking at how to work within regulations and foster the involvement of young people in their care. We will also be looking at the planning and executing a paediatric clinical trial and the ways this can vary according to region. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

Superbugs and Superdrugs

19 March 2018 - 20 March 2018

Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018. The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders from Nemesis Bioscience, ABAC Therapeutics, Oppilotech, Gladius Pharmaceuticals, Pew Charitable Trusts, Blueberry Therapeutics, UNT Health Science Center, ContraFect, SCYNEXIS; and government bodies such as MHRA and DNDi. The full speaker line-up and conference agenda is available at

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

Bioprocessing Summit Europe

20 March 2018 - 22 March 2018

Bioprocessing Summit Europe brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for today's bioprocessing needs. Created by the producers of PEGS, PepTalk and The Bioprocessing Summit Boston, this four-conference, scientifically driven event presents detailed case studies, technology updates, and best practice in cell culture, scale-up, recovery, purification, continuous manufacturing, process intensification, and bioproduction. Along with the impressive array of conferences, the Summit also features Short Courses, interactive Breakout Sessions and an extensive Exhibit Hall to provide in-depth coverage of critical bioprocess topics.

Sheraton Lisboa Hotel & Spa, Lisbon, Portugal

Drug Discovery

21 March 2018 - 22 March 2018

SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March. The pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently, the event will focus on key developments in this very industry. SMi’s 2nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery, CRISPR and PROTAC’s, as well as discussing advancements in medicinal chemistry, translational medicine and 3D structure based-discovery. With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Drug Discovery yet. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers: Chairman - Darren Green, Director of Computational Chemistry and Informatics, GlaxoSmithKline plc Chairman - Guido Hanauer, CEO, GHPC GmbH Steve Rees, Vice-President, Screening Sciences and Sample Management at AstraZeneca, Astra Zeneca Plc Claus Bendtsen, Executive Director/Sr Leader Data Science, AstraZeneca Ralph Minter, Director, Fellow, Antibody Discovery and Protein Engineering, MedImmune Stevan Djuric, Vice President, AbbVie John Harling, Director of Chemistry for the Protein Degradation DPU, GlaxoSmithKline plc Ursula Egner, Director Process Simulation and Design Collaboration, Bayer HealthCare

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

15th Annual Controlled Release Delivery

21 March 2018 - 22 March 2018

Building on the success of previous events, SMi's Controlled Release Delivery conference returns for its 15th year in London on 21-22 March 2018. As physicians and scientists continue to find strategies to assist in simplifying treatment schedules for patients, a pharma focus continues to move towards innovative controlled release technologies to improve drug transport to target. Moreover, with the global oral controlled release drug delivery technology market expected to flourish in the next few years, now is the time to get ahead of the game by exploring and understanding innovations in oral-lipid based and abuse deterrent formulations, nanoparticles and nanotechnologies, taste-masking and controlled release approaches, 3D printed dosage forms and functional film coats. Featuring presentations to analyse and evaluate latest advancements in drug delivery, this year's event highlights include: • Formulation of Controlled Release Delivery Technologies and improving the design of new controlled release delivery systems • Innovative additions to Oral Controlled Release Delivery Technologies, to improve the pharmacokinetic-pharmacodynamic properties of the drug • Latest regulation guidance and their implications for the pharmaceutical industry • Clinical developments and lessons learnt during clinical trials, through case studies with top pharmaceutical companies Featured speakers include senior decision makers and innovators from University of Strathclyde, GSK, Ipsen, PLIVA, SiTech Pharmabio, Grunenthal, Colorcon, Bial, Peptigel Design, University of Central Lancashire and more! Visit the event website to view the full list of speakers and their presentations. EARLY BIRD : Book by 30 November to save £400. Book by 15 December to save £200. Book by 31st January to save £100.

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

5th UK Pharmacogenetics and Stratified Medicine Network Annual Open Meeting

21 March 2018

The UK Pharmacogenetics and Stratified Medicine Network is dedicated to developing collaborative partnerships between healthcare professionals, academic researchers, industry partners, regulatory bodies and patients to synergise research into stratified medicine across the UK and support its adoption into the clinic.

30 Euston Square, London NW1 2FB

Peptide Discovery & Delivery

26 March 2018 - 27 March 2018

CHI's Peptide Discovery and Delivery conference reveals the latest strategies at the forefront of peptide discovery, chemistry and delivery with in-depth sessions on new chemistries, novel delivery mechanisms and the most important preclinical and clinical updates, helping you develop the next-generation of peptides therapeutics, including latest developments in antimicrobial peptides, peptide vaccines and macrocyclic and constrained peptides. Coverage Includes: • Is Glucagon a Suitable Drug Target? • New Peptide Developments • Macrocyclic and Contrained Peptides • Peptides for Cancer - Vaccines and Conjugates • Peptide Developments • Improving Peptide Delivery • Peptide Stability, Antimicrobials and Preparing for Commercialization

Boston Marriott Cambridge, MA, USA

Drug Discovery for Rare Diseases

28 March 2018

Rare diseases, or diseases that affect only a small percentage of the population, have been growing in significance and prominence in recent years. According to the National Institutes of Health, there are nearly 7000 rare diseases and more than 25 million Americans who are affected. Approximately 80% of these rare diseases are genetic in origin. Cambridge Healthtech Institute's symposium on Drug Discovery for Rare Diseases will bring together leading scientists, clinicians, executives and experts who are deeply involved in bringing to market the treatments for such rare disorders. This symposium will bring to light some of the new drug targets, and peptide and oligonucleotide-based drug modalities that are being pursued. This unique one-day event will bring together people from diverse backgrounds to tackle translational challenges and to discuss potential opportunities in this field. The goal is to help attendees and sponsors meet scientific and technical experts who are involved in rare disease research to exchange ideas and set up collaborations.

Boston Marriott, Cambridge, MA, USA